Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Mustang Bio Inc Is A Clinical-Stage Biopharmaceutical Company Focused On Translating Today'S Medical Breakthroughs Into Potential Cures For Difficult-To-Treat Cancers. It Acquires Rights To These Technologies By Licensing Or Otherwise Acquiring An Ownership Interest In The Technologies, Funding Their Research And Development, And Eventually Either Out-Licensing Or Bringing The Technologies To Market. Its Pipeline Is Currently Focused On The Core Areas Of Gene Therapies For Rare Genetic Disorders, Chimeric Antigen Receptor (Car) Engineered T Cell (Car T) Therapies For Hematologic Malignancies, And Car T Therapies For Solid Tumors.